Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC Blocks for Cardiac Surgery
NCT05589363Phase 4Withdrawn
- Sponsor
- Duke University
- Start
- Nov 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Duke University. Primary endpoint: Cumulative opioid consumption from extubation to 24 hours post-extubation. Planned start Nov 2024; status: withdrawn.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05589363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05589363.